11th Annual Update on Cardiopulmonary Bypass

March 12-17, 2006
The Fairmont Chateau Whistler
Whistler, British Columbia, Canada

Co-Sponsored by the Society of Cardiovascular Anesthesiologists and the Canadian Society of Perfusionists

Tuesday, March 14, 2006

Inflammation and Coagulation in Cardiopulmonary Bypass
Moderators: L Shore-Lesserson and BD Spiess

6:15 - 7:00 am Continental Breakfast with Exhibitors
7:00 - 7:30 am The Interaction of Inflammation and Coagulation - M England
7:30 - 8:00 am Perfusion Techniques to Reduce Inflammation - C Vocelka
8:00 - 8:30 am Pharmacologic Techniques to Reduce Inflammation - L Shore-Lesserson
8:30 - 9:00 am What are the End-organ Effects of Reducing Inflammation? - GS Aldea
9:00 - 9:30 am Case Discussion: Emergency Patient from the Cath Lab - L Shore-Lesserson

Heparin-induced Thrombocytopenia
Moderators: A DeAnda and GS Aldea

3:30 - 4:00 pm Refreshment Break with Exhibitors
4:00 - 4:30 pm The Overview of the Physiology of Heparin-induced Thrombocytopenia
BD Spiess
4:30 - 5:00 pm The Far Reaching Implications of Heparin Platelet Factor-4 Antibodies
A DeAnda
5:00 - 5:30 pm The Human Trials of Direct Thrombin Inhibitors - GS Aldea
5:30 - 6:00 pm A Perfusionist’s Tricks of the Trade with Regards to New or Novel Anticoagulants - C Vocelka
6:00 - 6:15 pm Case Discussion and Q & A - A DeAnda

Table of Contents




© Society of Cardiovascular Anesthesiologists
Questions or comments? Please send email to webmaster@scahq.org